Jitprawet N.Sujjitjoon J.Maneethorn P.Semprasert N.Kooptiwut S.Mahidol University2025-08-292025-08-292025-01-01Molecular Nutrition and Food Research (2025)16134125https://repository.li.mahidol.ac.th/handle/123456789/111867Steroid-induced diabetes is a well-known side effect of prolonged glucocorticoid (GC) treatment. Endoplasmic reticulum (ER) stress has been identified as one of the mechanisms underlying GC-induced pancreatic β-cell apoptosis. Recent studies suggest a connection between ER stress and the NLRP3 inflammasome, which promotes cell apoptosis. Genistein, a phytoestrogen, has demonstrated protective effects against pancreatic β-cell apoptosis induced by toxic agents. This study aims to investigate whether genistein protects against dexamethasone-induced pancreatic β-cell apoptosis by reducing ER stress and NLRP3 inflammasome activation. This study demonstrates that dexamethasone induces pancreatic β-cell apoptosis by increasing cPARP protein expression. Dexamethasone upregulates SERCA, IRE1-α, and sXBP expressions, while increasing pJNK and Bax and decreasing Bcl-2 protein expressions. Furthermore, dexamethasone upregulates TXNIP, a link protein between ER stress and the NLRP3 inflammasome, and increases NLRP3 and ASC, components of the NLRP3 inflammasome, leading to increase IL-1β expressions. Co-treatment of dexamethasone with genistein decreases cPARP expression, reduces SERCA, IRE1-α, sXBP, pJNK, and Bax, and induces Bcl-2 expressions. Co-treatment significantly decreases TXNIP, NLRP3, ASC, and IL-1β expressions. Similar results were observed in pancreatic islets for cPARP, NLRP3, and IL-1β. This study demonstrates that genistein protects against dexamethasone-induced pancreatic β-cell apoptosis by decreasing ER stress and the NLRP3 inflammasome.Biochemistry, Genetics and Molecular BiologyAgricultural and Biological SciencesArticleSCOPUS10.1002/mnfr.702182-s2.0-10501388829816134133